Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Baltimore currently holds 60,000 shares of Regulus Therapeutics Inc. (RGLS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Baltimore has been a net seller of RGLS stock. They have purchased $0 and sold $4.1M worth of shares.
David Baltimore's most recent insider trade was on May 20, 2024, when they sold 60,000 shares at $0.00 per share.
David Baltimore serves as Executive at Regulus Therapeutics Inc. (RGLS). They have executed 48 insider transactions totaling $4.1M over their tenure at the company.
David Baltimore holds the position of Executive at Regulus Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
David Baltimore has shown a selling trading pattern, with $0 in total purchases and $4.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Baltimore was on Dec 22, 2011, when they sold $900.8K worth of AMGN shares. This transaction involved 14,267 shares at $63.14 per share.
David Baltimore currently owns 60,000 shares of Regulus Therapeutics Inc. (RGLS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Baltimore's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Baltimore has 48 Form 4 filings on record as an insider at Regulus Therapeutics Inc..
Set alerts for David Baltimore and 40,000+ other insiders.